Berkner K L, Pudota B N
Lerner Research Institute, Cleveland Clinic Foundation, Department of Molecular Cardiology, OH 44195, USA.
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):466-71. doi: 10.1073/pnas.95.2.466.
Vitamin K-dependent (VKD) proteins require modification by the VKD-gamma-glutamyl carboxylase, an enzyme that converts clusters of glus to glas in a reaction that requires vitamin K hydroquinone, for their activity. We have discovered that the carboxylase also carboxylates itself in a reaction dependent on vitamin K. When pure human recombinant carboxylase was incubated in vitro with 14CO2 and then analyzed after SDS/PAGE, a radiolabeled band corresponding to the size of the carboxylase was observed. Subsequent gla analysis of in vitro-modified carboxylase by base hydrolysis and HPLC showed that all of the radioactivity could be attributed to gla residues. Quantitation of gla, asp, and glu residues indicated 3 mol gla/mol carboxylase. Radiolabeled gla was acid-labile, confirming its identity, and was not observed if vitamin K was not included in the in vitro reaction. Carboxylase carboxylation also was detected in baculovirus-(carboxylase)-infected insect cells but not in mock-infected insect cells, which do not express endogenous VKD proteins or carboxylase. Finally, we showed that the carboxylase was carboxylated in vivo. Carboxylase was purified from recombinant carboxylase BHK cells cultured in the presence or absence of vitamin K and analyzed for gla residues. Carboxylation of the carboxylase only was observed with carboxylase isolated from BHK cells cultured in vitamin K, and 3 mol gla/mol carboxylase were detected. Analyses of carboxylase and factor IX carboxylation in vitro suggest a possible role for carboxylase carboxylation in factor IX turnover, and in vivo studies suggest a potential role in carboxylase stability. The discovery of carboxylase carboxylation has broad implications for the mechanism of VKD protein carboxylation and Warfarin-based anti-coagulant therapies that need to be considered both retrospectively and in the future.
维生素K依赖性(VKD)蛋白需要由VKD-γ-谷氨酰羧化酶进行修饰才能发挥活性,该酶在需要维生素K对苯二酚的反应中将多个谷氨酸(glu)转化为γ-羧基谷氨酸(gla)。我们发现,该羧化酶还会在依赖维生素K的反应中对自身进行羧化。当将纯的人重组羧化酶与14CO2在体外孵育,然后通过SDS/PAGE分析时,观察到一条与羧化酶大小相对应的放射性标记条带。随后通过碱水解和HPLC对体外修饰的羧化酶进行gla分析,结果表明所有放射性都可归因于gla残基。对gla、天冬氨酸(asp)和谷氨酸(glu)残基的定量分析表明,每摩尔羧化酶含有3摩尔gla。放射性标记的gla对酸不稳定,这证实了其身份,并且如果体外反应中不包含维生素K,则不会观察到放射性标记的gla。在杆状病毒(羧化酶)感染的昆虫细胞中也检测到了羧化酶的羧化,但在未感染的昆虫细胞中未检测到,未感染的昆虫细胞不表达内源性VKD蛋白或羧化酶。最后,我们表明羧化酶在体内也会发生羧化。从在有或没有维生素K的情况下培养的重组羧化酶BHK细胞中纯化羧化酶,并分析gla残基。仅在从在维生素K中培养的BHK细胞中分离出的羧化酶中观察到羧化酶的羧化,并且检测到每摩尔羧化酶含有3摩尔gla。体外对羧化酶和因子IX羧化的分析表明,羧化酶羧化在因子IX周转中可能起作用,而体内研究表明其在羧化酶稳定性方面可能起作用。羧化酶羧化的发现对VKD蛋白羧化机制以及基于华法林的抗凝疗法具有广泛影响,需要回顾过去并在未来加以考虑。